It was in May, 1938 that Hertz et al. (1) published the first report on biological studies with a radioactive isotope of iodine. By today's standards these first studies were done under the least favorable conditions with an isotope whose half life of 25 minutes limited the studies that could be done. Notwithstanding the limitations put on these investigators they not only reaffirmed certain principles of thyroid physiology, but with other investigators, Hamilton (2) , Hamilton and Soley (3), and LeBlond and Sue (4) , who began working with radioactive isotopes of iodine in other laboratories at about the same time, they pioneered in a new field of investigating the thyroid. Today we have a small army of investigators bringing together a variety of disciplines, i.e., physics, chemistry, embryology, physiology, histochemistry, pathology and clinical medicine in studying with radioactive iodine and other tools normal and morbid physiology of the thyroid. Many of these investigators are students whose primary interests are related to studies of normal and abnormal function of the thyroid. These students are delighted to have made available so many new technics with which to increase our knowledge of thyroid physiology. Many of the investigators in this field are interested primarily in isotopic methods and their application to studies in biology. They probably have been attracted to this field because of the unique avidity of the thyroid for iodine which makes this an ideal tissue for applying isotopic methods, and for studying the biologic effects of irradiation with such isotopes.
At the present time, it seems quite proper to ask questions such as those posed by Dr. William T. Salter preceding the 1948 Symposium on Radio Iodine at the Brookhaven National Laboratory. "1. How has radio iodine improved our knowledge of iodine metabolism and of the physiology and the therapy of the thyroid? 2. How do the results harmonize with past experience?" The purpose of this paper is to review the contributions made to our knowledge of human thyroid disease by studies with radioactive iodine.
The earliest studies done at the clinical level by Hamilton and Soley (3) reaffirmed our previous concepts that the human thyroid has an avidity for iodine. These investigators compared the collection by the thyroid of iodine labelled with radio iodine and its excretion in the urine and feces in normal subjects and in patients having various thyroid disorders. They found that an orally administered dose of labelled iodine was absorbed rapidly and could be detected in the thyroid within 20 minutes. In normal subjects 74 to 89 per cent of the dose was excreted during a five-day period with the major portion appearing during the first 24 hours. Two myxedematous patients excreted 91 and 94 per cent in the urine during five days but at a much slower rate than did the normals. Thyrotoxic patients previously treated with iodine excreted about the same amount of iodine as did normal individuals. Fecal excretion of these labelled doses of iodine averaged only about 1 per cent of the dose. In another series of studies Hamilton and Soley (5) recorded the characteristic collection curves obtained by in sivo measurements for various thyroid states. The curve that they observed to be typical for normal thyroids was a smooth curve which leveled off to a flat plateau in two days. The initial collection by thyroids of hyperthyroid patients was greater and much more rapid than in normal thyroids but decreased almost as rapidly to a plateau lower than that of the normal thyroids. This phenomenon was also observed in two goiterous hypothyroid children (Hamilton, et al. [6] ). This rapid decrease to a lower than normal plateau following an increased pickup observed in the goiterous children and hyperthyroid individuals might be attributed to the fact that these investigators were using 14 mgm. of inert iodide as carrier. This concept is supported by their failure to observe the rapid loss of radio iodine from the thyroid when a carrier dose of 0.1 pg. of sodium iodide was given.
USE OF RADIOACTIVE IODINE IN THYROID DISEASE STUDY
This explanation is further supported by the observations of Hertz et al. (7) who administered radioactive iodine with varying amounts of carrier iodide to patients suffering with Graves' disease at varying stages of preoperative treatment with potassium iodide. They observed that the untreated hyperplastic thyroids of Graves' disease collected 80 per cent or more of the labelled iodine if the dose was small. They also observed that with increasing time intervals after the administration of isotopic iodine there was an increasing amount of radioactive iodine in the thyroxine-like fraction of the gland.
Since these comparatively earlier observations, a number of investigators have used isotopic technics in studying the role of iodine in normal and abnormal thyroid physiology.
Chapman et al. (8) have studied the collection of radio iodine by the human fetus. They administered tracer doses of J131 12 to 48 hours before operation to pregnant women who because of organic disease were coming to therapeutic abortion. The intact fetus was fixed in formalin and then sectioned longitudinally, one half was taken for measurements of radioactivity and the other half was examined histologically. They observed that fetuses less than 12 weeks old did not concentrate any measurable amount of labelled iodine. In those fetuses which varied in age from 14 to 32 weeks the thyroids showed an avidity for iodine which seemed to increase with the age of the fetus. It is of interest that these investigators were able to confirm the opinion that the onset of function as measured in this manner is correlated with the appearance of definite follicles containing colloid.
Astwood and Stanley (9) studied the rate of accumulation of radioactive iodine by the thyroid in 70 normal humans. By plotting the counting rate per second obtained at a standard distance from the thyroid against the square root of the elapsed time in minutes they were able to plot a straight line which continued for about eight hours from which they were able to determine an accumulation gradient. In normal humans they found this accumulation gradient to vary between the limits of 1.5 and 36.4 with a mean of 9.3. Myxedematous patients were found to have accumulation gradients of 0.5 to 1.9 and thyrotoxic patients receiving no treatment at the time of testing were found-to have gradients which varied between 17.0 and 43.6.
Keating et al. (10) followed the rate of radioactive iodine excretion in patients who had received 100 microcuries of I131 with 100 Mig. of carrier iodine. By mathematical analysis their urinary excretion curves yielded four quantities: 1. The renal fraction (that fraction of the dose excreted in the urine) ; 2. The disappearance rate (the proportional rate of disappearance from the blood); 3. The renal excretion rate; and 4. The collection rate (the proportional rate of disappearance into other sites than the kidneys which they interpreted as an index of thyroid collection rate). They found the renal fraction to be greater than normal in hypothyroid patients and less than normal in hyperthyroid patients. The disappearance rates they found to be less in hyp6thyroid patients and markedly greater than normal in patients having hyperthyroidism. The most significant variation that they observed was in the collection rates which were much less than normal in hypothyroid states and averaged six times the normal in hyperthyroid patients.
These marked variations from normal in the collection of iodine by the thyroid or the urinary excretion of radio iodine in hypothyroidism and in hyperthyroidism have prompted many investigators to use such methods of study as a means of diagnosing abnormal states of thyroid function. Quimby and McCune (11) , who used in vivo measuring technics, found that children who clinically were euthyroid concentrated and retained in their thyroids about 12 per cent of an administered dose of radio iodine. They found that hyperthyroid children concentrated and retained several fold the value obtained in euthyroid children whereas hypothyroid children concentrated as little as 1 per cent or less of the dose. McArthur et al. (12) followed the urinary excretion of radio iodine in a series of patients and observed the urinary excretion of 22 (20) have demonstrated that thyroxine when administered to hypophysectomized rats partially inhibits the action of administered thyroid-stimulating hormone on the thyroid. It would be interesting to compare the effects of thyroid-stimulating hormone on the accumulation gradients of radio iodine in the same euthyroid subjects before and after treatment with desiccated thyroid. Stanley and Astwood (18) suggest that this method of' study might be of value in determining whether or not a patient being treated with desiccated thyroid does or does not have a potentially functional thyroid gland.
Studies with radioactive iodine have been of value not only in determining the mode of action of certain thyroid-inhibiting agents but such studies have also been of value in quantitating the effects of a variety of these drugs. In 1943 Rawson et al. (21) reported a patient who had developed a large goiter, while taking potassium thiocyanate in treatment of hypertension. Biopsy of this gland showed an extreme hyperplasia. Only a small per cent of a tracer of 1131 given to this patient was excreted in the urine. Unfortunately this observation was not correlated with the blood thiocyanate level.
Subsequent studies by Haines (22) and by Richards (23) done in several patients having "thiocyanate goiter" have revealed that the excretion of radioactive iodine by such goiterous patients can be related to the blood thiocyanate levels observed in such patients. If 'the thiocyanate level is elevated, most of the iodide is excreted; if it is low, less of the iodide is excreted.
Rawson et al. (24) used radio iodine tracer technics in evaluating the action of thiouracil on the thyroids of Graves' disease. They prepared patients for thyroidectomy by administering thiouracil. Preoperatively they gave ten of their patients tracer doses of I131 and determined the radioactive iodine excreted in the urine and that recoverable in the operatively removed thyroids. They found that most of the tracer iodine was excreted in the urine and that only a small per cent was contained in the thyroids. They concluded that this drug acted to interfere with the synthesis of thyroid hormone by setting up a block to the collection or the utilization of iodide.
Studies done by Stanley and Astwood (25) have demonstrated that in thyrotoxic humans the thiouracil group of drugs causes an inhibition to the organic bindings of iodine (which must first have been accumulated by the thyroid as iodide) to thyroid protein. By measuring with in vivo methods the pickup of radio iodine by the thyroid they were able to demonstrate that the thyroid, though well controlled by the administered drug, was capable of concentrating iodide in the thyroid. That this collected 1131 existed as iodide in the wellcontrolled gland was evidenced by the fact that the administration of large doses of potassium iodide resulted in a sudden decrease in the activity over the thyroid. They also demonstrated that the administration of potassium thiocyanate resulted in a prompt discharge of accumulated iodide from the thyroid. It is interesting that bromide was observed by these investigators to have no effect on the collected iodide. Patients receiving thiouracil or related agents in doses inadequate to control their thyrotoxicosis when injected with potassium thiocyanate were found to discharge only a fraction of the accumulated radio iodine and were concluded to be receiving inadequate amounts of the drug to inhibit the binding of iodine to the thyroid protein. It has been suggested by Stanley and Astwood (25) that this method of study would be of value in determining the adequacy of dose in patients undergoing treatment with any of these agents. On the basis of these observations it is apparent that the first step in storing iodine in the thyroid is that of concentrating it as iodide in an iodide space or trap. It would appear from these studies that the pickup of iodide is not dependent upon the rate of iodination of the hormone. On the other hand we have observed that the pickup of iodine by the thyroids of rats under the influence of thiouracil is only a fraction of that collected by thyroids of untreated controls even at 10 minutes after administering the tracer iodine. Notwithstanding this demonstration that the iodine is first concentrated as iodide we still do not understand the mechanism by which the iodide is accumulated in the thyroid nor are we able to explain the increased avidity for iodine by the hyperplastic thyroids of Graves' disease nor by the thyroids of animals previously treated with thyrotrophic hormone.
Stanley and Astwood (26) have compared and quantitated the thyroid-inhibiting properties of several goitrogenic agents on the thyroids of human subjects. The method that they used depended on the capacity of these agents to modify the accumulation gradients of radioactive iodine by the thyroids as detected by serial counts with an externally placed Geiger-Mueller counter. The values obtained by these investigators are considerably different from those obtained by methods which depend upon the goitrogenic effects of these drugs in rats. For example, whereas propyl thiouracil has goitrogenic properties in the rat which are 10 times those of thiouracil, by this method of assay propyl thiouracil has only 0.75 the activity of thiouracil. Likewise, thiourea, an agent possessing only 0.1 the goitrogenic activity of thiouracil in the rat is equally as effective as thiouracil in altering the accumulation gradient in human thyroids.
Rawson and McGinty (27, 28) , who compared the minimal doses of various injected drugs necessary to inhibit significantly the concentration of radioactive iodine in the chick thyroid found that propyl thiouracil was no more effective than thiouracil whereas by tests of goitrogenesis in the rat propyl thiouracil was 10 times more active than thiouracil. These same investigators found that benzyl thiouracil was 10 times as effective as thiouracil in inhibiting the concentration of radioactive iodine in the thyroid of a chick. Stanley and Astwood (26) The mechanism by which the various salts of iodine exert their well-known therapeutic effect in Graves' disease has long remained unexplained. Indeed when one considers that the thyroid of untreated Graves' disease has an increased avidity for iodine which it rapidly converts and secretes into the circulation as thyroid hormone, the administration of iodine to such patients would seem to be an unwise maneuver. However, notwithstanding these theoretical contraindications, the therapeutic value of iodine in Graves' disease is a well-established fact. Plummer (30) who established the value of this therapeutic measure advanced the hypothesis that the toxic effects of Graves' disease were due to the elaboration of an incompletely iodinated hormone molecule. He suggested that the therapeutic action of iodine in this disease resulted from complete iodination of the hormone which even in excess was less toxic than the abnormal hormone.
In contrast to the two-hormone theory advanced by Plummer (30), Rawson et al. (31) have advanced a theory that iodine has two actions on the thyroid, an iodinating or a nutritive action and an involuting action on the thyroid of Graves' disease and have reported that they had been able to separate these two actions of iodine on the thyroid. They studied patients having Graves' disease before any medication was given, after treatment with thiouracil had caused a fall in the basal metabolic rate to a normal level, and after iodine had been added to the regime of treatment with thiouracil. Observations included micro-histometric studies of biopsy specimens taken before treatment, after treatment with thiouracil, but before administering iodides, and of glands removed at operation after treatment with both drugs. The urinary excretion of radioactive iodine was determined before and during treatment with thiouracil. Total and thyroglobulin iodines were determined in the operatively removed thyroids. The results showed hyperplasia of the thyroid samples removed before starting treatment with mean acinar cell heights which averaged 12.0 micra. There was an increase in thyroid hyperplasia after treatment with thiouracil, the mean acinar cell heights averaging 13.9 micra. However, involution was observed after iodine had been adminis- Figure 1 . The radioactivity demonstrated in this patient's operatively removed thyroid was too little to measure and the thyroglobulin-iodine value was only 2.3 mgm. per cent. Notwithstanding the fact that this gland failed to accumulate or to convert the administered iodine to thyroglobulin, the thyroid tissue examined after treatment with sodium iodide was well involuted in contrast to an extreme hyperplasia observed in the biopsy specimen taken just before adding iodine to the treatment. See Figure 2 . This separation of the involuting action of iodine from its nutritive action, these investigators believe, may explain the paradoxical effect of iodine in Graves' disease. They also suggested that the involuting effect of iodine in Graves' disease was due to an inhibitory action of this agent to the action of thyrotrophic hormone on the thyroid cell.
Space will not permit further discussion as to the mechanism of this involuting action of iodine on the thyroid. However, attention should be called to the reports of Wolff and Chaikoff (32), who by using tracer technics have demonstrated in rats that the maintenance of an inorganic blood iodide level of 200 jug. per cent or more interferes with the organic binding of iodine by the thyroid. They suggest that the level of plasma iodide is part of a homeostatic mechanism which governs hormone synthesis in the normal gland.
Although there is good evidence that endemic goiter is due to a deficiency of iodine intake, it is difficult to explain the development of such nontoxic goiters in certain patients who apparently have an adequate intake of iodine. Many students of thyroid disease have suspected the existence of positive goitrogens which play a role in the development of some of the non-toxic goiters developing in subjects whose iodine intakes by accepted standards are more than adequate. Greer and Astwood (33) have demonstrated that certain foods have an inhibitory effect to the accumulation of radio iodine. They have evaluated the effects of 61 different food substances on the "accumulation gradient" of radio iodine in normal hu- (40) reported two cases of adenocarcinoma with functioning metastases and hyperthyroidism which they studied with radioactive iodine. One of these patients had been totally thyroidectomized in 1923. Tracer studies with radioactive iodine done in this patient demonstrated that there was no functioning thyroid tissue in the neck and that the source of hyperthy- Following these observations several investigators interested in using radio iodine in the therapy of cancer of the thyroid have undertaken studies with radio iodine concerning the natural avidity of various thyroid cancers for radio iodine and means of increasing the capacity of such tumors to concentrate radioactive iodine. February 28, 1945 , complaining of a soft tissue mass in the skull and of regrowth of a goiter. She gave a history of having had surgical removal in 1933 of a thyroid nodule which had existed for five years. She reported that one year before admission to this clinic she had first noted a lump over the occiput, and that six months before admission she had noted an extensive regrowth of her goiter. She was found to have a lemon-sized, moderately firm mass in the left occipitoparietal area measuring about 5 X 6 cm. in diameter and raised about 2 cm. above the rest of the skull. She was also found to have a walnutsized, hard mass in the upper pole of the right lobe of the thyroid. Several large firm lymph nodes were palpable in the right anterior cervical chain. Clinically she was euthyroid and her basal metabolic rate was minus 12 per cent. X-ray studies of the chest and skeleton revealed only an osteolytic defect in the left parietal bone consistent with destruction by metastatic disease.
Tracer studies done with radioactive iodine revealed that the occipital metastasis was capable of concentrating only minimal amounts of iodine. It was reasoned that removal of her normal thyroid might be followed by a significant pickup of iodine by the skull metastasis. On March 6, 1945, Dr. R. R. Linton did a total thyroidectomy and a right radical neck dissection. At the same time a biopsy specimen was removed from the metastatic lesion in the skull. The thyroid showed a follicular adenocarcinoma. A similar picture was found in the small metastasis though this lesion showed more differentiation than the primary lesion and contained some colloid filled acini. Her normal thyroid was found to have collected 1.8 per cent of the preoperatively administered radioactive iodine per gram of tissue. The skull metastasis was found to have collected only 0.06 per cent of administered radio iodine per gram of tissue.
On March 27, another tracer dose of radioactive iodine was administered and in vizvo measurements over the metastatic lesion were made. Though the patient was found to concentrate less than 3 per cent of administered iodine in the skull metastasis, she did not develop myxedema in a period of four months. Indeed, in July 1945, her basal metabolic rate was plus 4 The time required to observe these changes subsequent to thyroidectomy varied between one month and 32 months. In four cases of pure papillary adenocarcinoma that they studied, total thyroidectomy had no effect on the function of previously non-functioning metastasis. These same investigators have likewise reported that the avidity for radio iodine of certain functioning cancers of the thyroid can be increased by administering thyroid-stimulating hormone. They have also observed that prolonged treatment with thiouracil may be followed by considerable increase in the 1343 iodine accumulating capacity of certain functioning cancers of the thyroid. This described effect of prolonged treatment with thiouracil might be ascribed to an increased elaboration and augmentation in action of the patient's own thyroid-stimulating hormone.
These observations in which it has been demonstrated that the function of metastatic cancer of the thyroid can be altered by removal of the normal thyroid or by administering thyroid-stimulating hormone suggest that this cancer is not wholly autonomous but is capable of responding to certain physiologic stimuli. They also provide us with concepts which may lead to a more complete understanding of the biology of this type of a neoplasm. It is hoped that these concepts may also be applied in studying neoplasms of other tissues as well.
In the light of present knowledge, our understanding as to the mechanisms through which the thyroid hormone exerts its actions on the cells of the body is a void. Recent studies, however, indicate that tracing labelled thyroid hormone through its circuit may throw some light on the mode of action of this hormone. Gross and LeBlond (47) have observed that thyroxine labelled with 1131 when administered to intact rats is withdrawn from the blood stream and is demonstrable in various tissues within two hours of its administration. They also observed that it is broken down within the body to diiodotyrosine and iodide. Hamilton, 1948 (48) and Keating and Albert (49) have observed the fate of radio iodine labelled thyroxine, thyroglobulin and iodinated casein in myxedematous patients. They have observed that less than 5 per cent of the labelled iodine is excreted in the feces and that the rest is excreted in the urine. They have found that more than 90 per cent of the labelled iodine excreted in the urine is excreted as iodide and that the remainder is excreted as diiodotyrosine. One might suggest on the basis of these studies that the thyroid hormone in the process of exerting its action is broken down and the iodine liberated to be excreted or utilized in the synthesis of thyroid hormone. It is to be hoped that these studies are only the beginning of investigations which may elucidate the mode of action of the thyroid hormone. 
